Literature DB >> 19370765

Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders.

Margarita Muiños-Gimeno1, Monica Guidi, Birgit Kagerbauer, Rocío Martín-Santos, Ricard Navinés, Pino Alonso, José M Menchón, Mònica Gratacòs, Xavier Estivill, Yolanda Espinosa-Parrilla.   

Abstract

Genetic and functional data indicate that variation in the expression of the neurotrophin-3 receptor gene (NTRK3) may have an impact on neuronal plasticity, suggesting a role for NTRK3 in the pathophysiology of anxiety disorders. MicroRNA (miRNA) posttranscriptional gene regulators act by base-pairing to specific sequence sites, usually at the 3'UTR of the target mRNA. Variants at these sites might result in gene expression changes contributing to disease susceptibility. We investigated genetic variation in two different isoforms of NTRK3 as candidate susceptibility factors for anxiety by resequencing their 3'UTRs in patients with panic disorder (PD), obsessive-compulsive disorder (OCD), and in controls. We have found the C allele of rs28521337, located in a functional target site for miR-485-3p in the truncated isoform of NTRK3, to be significantly associated with the hoarding phenotype of OCD. We have also identified two new rare variants in the 3'UTR of NTRK3, ss102661458 and ss102661460, each present only in one chromosome of a patient with PD. The ss102661458 variant is located in a functional target site for miR-765, and the ss102661460 in functional target sites for two miRNAs, miR-509 and miR-128, the latter being a brain-enriched miRNA involved in neuronal differentiation and synaptic processing. Interestingly, these two variants significantly alter the miRNA-mediated regulation of NTRK3, resulting in recovery of gene expression. These data implicate miRNAs as key posttranscriptional regulators of NTRK3 and provide a framework for allele-specific miRNA regulation of NTRK3 in anxiety disorders. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370765     DOI: 10.1002/humu.21005

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  38 in total

Review 1.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

2.  Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals.

Authors:  Cortney A Turner; Sarah M Clinton; Robert C Thompson; Stanley J Watson; Huda Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study.

Authors:  Antonio Terracciano; Maria Grazia Piras; Monia Lobina; Antonella Mulas; Osorio Meirelles; Angelina R Sutin; Wayne Chan; Serena Sanna; Manuela Uda; Laura Crisponi; David Schlessinger
Journal:  World J Biol Psychiatry       Date:  2011-11-02       Impact factor: 4.132

Review 4.  Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization.

Authors:  Hideto Takahashi; Ann Marie Craig
Journal:  Trends Neurosci       Date:  2013-07-05       Impact factor: 13.837

5.  Basal microRNA expression patterns in reward circuitry of selectively bred high-responder and low-responder rats vary by brain region and genotype.

Authors:  David E Hamilton; Christopher L Cooke; Bradley S Carter; Huda Akil; Stanley J Watson; Robert C Thompson
Journal:  Physiol Genomics       Date:  2014-02-25       Impact factor: 3.107

6.  A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in central south Chinese population.

Authors:  Li-Sha Wu; Fang-Fang Li; Liang-Dan Sun; Dai Li; Juan Su; Ye-Hong Kuang; Gang Chen; Xiao-Ping Chen; Xiang Chen
Journal:  Hum Genet       Date:  2011-06-08       Impact factor: 4.132

7.  Infralimbic Neurotrophin-3 Infusion Rescues Fear Extinction Impairment in a Mouse Model of Pathological Fear.

Authors:  Davide D'Amico; Thomas Gener; Maria Martínez de Lagrán; Maria V Sanchez-Vives; Mónica Santos; Mara Dierssen
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

8.  Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model.

Authors:  Mónica Santos; Davide D'Amico; Ornella Spadoni; Alejandro Amador-Arjona; Oliver Stork; Mara Dierssen
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

Review 9.  MicroRNA's impact on neurotransmitter and neuropeptide systems: small but mighty mediators of anxiety.

Authors:  Stefanie Martinetz
Journal:  Pflugers Arch       Date:  2016-04-30       Impact factor: 3.657

Review 10.  Translational approaches to anxiety: focus on genetics, fear extinction and brain imaging.

Authors:  Angelika Erhardt; Victor I Spoormaker
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.